Ezra Margono, Muhammad Mustafa Qureshi, Avneesh Gupta
{"title":"利用双层双能量 CT 区分肾脏增强和非增强病变的碘密度阈值","authors":"Ezra Margono, Muhammad Mustafa Qureshi, Avneesh Gupta","doi":"10.1097/RCT.0000000000001651","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to determine the optimal threshold iodine density to distinguish enhancing and nonenhancing renal masses with dual-layer dual-energy CT (dlDECT).</p><p><strong>Methods: </strong>In this retrospective, HIPAA-compliant, institutional review board-approved study, 383 consecutive renal mass dlDECT studies from September 5, 2018, through December 15, 2022, were reviewed for enhancing solid renal masses with ≥∆20 HU. Studies with simple cysts in the same interval served as controls. Lesion ROI HU measurements on unenhanced and nephrographic phases and ROI iodine density measurements of each lesion and the abdominal aorta for normalization were recorded. The mean lesion HU values and absolute and normalized iodine densities were compared with enhancing and nonenhancing renal lesions using a two-sample t test. The diagnostic accuracy of iodine thresholds was assessed by calculating sensitivity and specificity, with receiver operating characteristic curve and AUC analysis.</p><p><strong>Results: </strong>There were 38 enhancing and 39 nonenhancing renal lesions. The mean (standard deviation [SD]) ∆HU was 73.5 (38.7) and 3.9 (5.1) HU for enhancing and nonenhancing lesions, respectively. The mean absolute iodine density was significantly different for enhancing and nonenhancing lesions (3.2 [1.7] mg/mL and 0.20 [0.22] mg/mL, respectively; P < 0.0001). Normalized mean iodine density was significantly different for enhancing and nonenhancing lesions (0.62 [0.33] mg/mL and 0.04 [0.04] mg/mL, respectively; P < 0.0001). The optimal absolute iodine density threshold of 0.70 mg/mL (AUC, 0.999) and normalized iodine density threshold of 0.11 mg/mL (AUC, 0.999) were 100% sensitive and 97.4% specific for discriminating enhancing and nonenhancing renal lesions.</p><p><strong>Conclusions: </strong>This study provides absolute and normalized iodine density thresholds to distinguish enhancing and nonenhancing renal lesions with high sensitivity and specificity using dlDECT.</p>","PeriodicalId":15402,"journal":{"name":"Journal of Computer Assisted Tomography","volume":" ","pages":"50-56"},"PeriodicalIF":1.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Iodine Density Threshold to Distinguish Between Enhancing and Nonenhancing Renal Lesions With Dual-Layer Dual-Energy CT.\",\"authors\":\"Ezra Margono, Muhammad Mustafa Qureshi, Avneesh Gupta\",\"doi\":\"10.1097/RCT.0000000000001651\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aimed to determine the optimal threshold iodine density to distinguish enhancing and nonenhancing renal masses with dual-layer dual-energy CT (dlDECT).</p><p><strong>Methods: </strong>In this retrospective, HIPAA-compliant, institutional review board-approved study, 383 consecutive renal mass dlDECT studies from September 5, 2018, through December 15, 2022, were reviewed for enhancing solid renal masses with ≥∆20 HU. Studies with simple cysts in the same interval served as controls. Lesion ROI HU measurements on unenhanced and nephrographic phases and ROI iodine density measurements of each lesion and the abdominal aorta for normalization were recorded. The mean lesion HU values and absolute and normalized iodine densities were compared with enhancing and nonenhancing renal lesions using a two-sample t test. The diagnostic accuracy of iodine thresholds was assessed by calculating sensitivity and specificity, with receiver operating characteristic curve and AUC analysis.</p><p><strong>Results: </strong>There were 38 enhancing and 39 nonenhancing renal lesions. The mean (standard deviation [SD]) ∆HU was 73.5 (38.7) and 3.9 (5.1) HU for enhancing and nonenhancing lesions, respectively. The mean absolute iodine density was significantly different for enhancing and nonenhancing lesions (3.2 [1.7] mg/mL and 0.20 [0.22] mg/mL, respectively; P < 0.0001). Normalized mean iodine density was significantly different for enhancing and nonenhancing lesions (0.62 [0.33] mg/mL and 0.04 [0.04] mg/mL, respectively; P < 0.0001). The optimal absolute iodine density threshold of 0.70 mg/mL (AUC, 0.999) and normalized iodine density threshold of 0.11 mg/mL (AUC, 0.999) were 100% sensitive and 97.4% specific for discriminating enhancing and nonenhancing renal lesions.</p><p><strong>Conclusions: </strong>This study provides absolute and normalized iodine density thresholds to distinguish enhancing and nonenhancing renal lesions with high sensitivity and specificity using dlDECT.</p>\",\"PeriodicalId\":15402,\"journal\":{\"name\":\"Journal of Computer Assisted Tomography\",\"volume\":\" \",\"pages\":\"50-56\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Computer Assisted Tomography\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/RCT.0000000000001651\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Computer Assisted Tomography","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/RCT.0000000000001651","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究旨在确定使用双层双能 CT(dlDECT)区分增强和非增强肾肿块的最佳阈值碘密度:在这项符合 HIPAA 标准、经机构审查委员会批准的回顾性研究中,对 2018 年 9 月 5 日至 2022 年 12 月 15 日期间的 383 项连续肾肿块 dlDECT 研究进行了审查,以确定是否存在≥∆20 HU 的增强实性肾肿块。同一区间的单纯囊肿研究作为对照。记录了未增强期和肾造影期的病灶 ROI HU 测量值,以及每个病灶和腹主动脉的 ROI 碘密度测量值,以便进行归一化处理。采用双样本 t 检验比较增强和非增强肾脏病变的平均病变 HU 值、绝对碘密度和归一化碘密度。通过计算灵敏度和特异性、接收器操作特征曲线和 AUC 分析评估碘阈值的诊断准确性:结果:共有 38 例增强性肾病变和 39 例非增强性肾病变。增强病变和非增强病变的平均(标准差 [SD])∆HU 分别为 73.5 (38.7) HU 和 3.9 (5.1) HU。增强病灶和非增强病灶的平均绝对碘密度有显著差异(分别为 3.2 [1.7] mg/mL 和 0.20 [0.22] mg/mL;P <0.0001)。增强病灶和非增强病灶的归一化平均碘密度有显著差异(分别为 0.62 [0.33] mg/mL 和 0.04 [0.04] mg/mL;P <0.0001)。最佳绝对碘密度阈值为 0.70 mg/mL(AUC,0.999),归一化碘密度阈值为 0.11 mg/mL(AUC,0.999),对鉴别增强和非增强肾脏病变的敏感性为 100%,特异性为 97.4%:本研究提供了绝对碘密度阈值和归一化碘密度阈值,可使用 dlDECT 以较高的灵敏度和特异性区分增强和非增强肾脏病变。
Iodine Density Threshold to Distinguish Between Enhancing and Nonenhancing Renal Lesions With Dual-Layer Dual-Energy CT.
Purpose: This study aimed to determine the optimal threshold iodine density to distinguish enhancing and nonenhancing renal masses with dual-layer dual-energy CT (dlDECT).
Methods: In this retrospective, HIPAA-compliant, institutional review board-approved study, 383 consecutive renal mass dlDECT studies from September 5, 2018, through December 15, 2022, were reviewed for enhancing solid renal masses with ≥∆20 HU. Studies with simple cysts in the same interval served as controls. Lesion ROI HU measurements on unenhanced and nephrographic phases and ROI iodine density measurements of each lesion and the abdominal aorta for normalization were recorded. The mean lesion HU values and absolute and normalized iodine densities were compared with enhancing and nonenhancing renal lesions using a two-sample t test. The diagnostic accuracy of iodine thresholds was assessed by calculating sensitivity and specificity, with receiver operating characteristic curve and AUC analysis.
Results: There were 38 enhancing and 39 nonenhancing renal lesions. The mean (standard deviation [SD]) ∆HU was 73.5 (38.7) and 3.9 (5.1) HU for enhancing and nonenhancing lesions, respectively. The mean absolute iodine density was significantly different for enhancing and nonenhancing lesions (3.2 [1.7] mg/mL and 0.20 [0.22] mg/mL, respectively; P < 0.0001). Normalized mean iodine density was significantly different for enhancing and nonenhancing lesions (0.62 [0.33] mg/mL and 0.04 [0.04] mg/mL, respectively; P < 0.0001). The optimal absolute iodine density threshold of 0.70 mg/mL (AUC, 0.999) and normalized iodine density threshold of 0.11 mg/mL (AUC, 0.999) were 100% sensitive and 97.4% specific for discriminating enhancing and nonenhancing renal lesions.
Conclusions: This study provides absolute and normalized iodine density thresholds to distinguish enhancing and nonenhancing renal lesions with high sensitivity and specificity using dlDECT.
期刊介绍:
The mission of Journal of Computer Assisted Tomography is to showcase the latest clinical and research developments in CT, MR, and closely related diagnostic techniques. We encourage submission of both original research and review articles that have immediate or promissory clinical applications. Topics of special interest include: 1) functional MR and CT of the brain and body; 2) advanced/innovative MRI techniques (diffusion, perfusion, rapid scanning); and 3) advanced/innovative CT techniques (perfusion, multi-energy, dose-reduction, and processing).